Login / Signup

A Systematic Review of Efficacy and Safety of Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Voncento) in von Willebrand Disease.

Lucia RugeriWilliam ThomasKathrin SchirnerLisa HeyderGünter Auerswald
Published in: Thrombosis and haemostasis (2024)
 This review provides a comprehensive summary of studies that evaluated the use of pdVWF/FVIII in VWD demonstrating the long-term effectiveness and safety of this pdVWF/FVIII across all ages, types of VWD, and treatment settings.
Keyphrases
  • combination therapy
  • case control
  • smoking cessation